Literature DB >> 7578443

Characterization of the humoral immune response to porcine reproductive and respiratory syndrome (PRRS) virus infection.

K J Yoon1, J J Zimmerman, S L Swenson, M J McGinley, K A Eernisse, A Brevik, L L Rhinehart, M L Frey, H T Hill, K B Platt.   

Abstract

The development of the humoral immune response against porcine reproductive and respiratory syndrome (PRRS) virus was monitored by an indirect fluorescent antibody (IFA) test, immunoperoxidase monolayer assay (IPMA), enzyme-linked immunosorbent assay (ELISA), and serum virus neutralization (SVN) test over a 105-day period in 8 pigs experimentally infected with ATCC strain VR-2402. Specific antibodies against PRRS virus were first detected by the IFA test, IPMA, ELISA, and the SVN test 9-11, 5-9, 9-13, and 9-28 days postinoculation (PI), respectively, and reached their maximum values by 4-5, 5-6, 4-6, and 10-11 weeks PI, respectively, thereafter. After reaching maximum value, all assays showed a decline in antibody levels. Assuming a constant rate of antibody decay, it was estimated by regression analysis that the ELISA, IFA, IPMA, and SVN antibody titers would approach the lower limits of detection by approximately days 137, 158, 324, and 356 PI, respectively. In this study, the immunoperoxidase monolayer assay appeared to offer slightly better performance relative to the IFA test, ELISA, and SVN test in terms of earlier detection and slower rate of decline in antibody titers. Western immunoblot analysis revealed that antibody specific for the 15-kD viral protein was present in all pigs by 7 days PI and persisted throughout the 105-day observation period. Initial detection of antibodies to the 19-, 23-, and 26-kD proteins varied among pigs, ranging from 9 to 35 days PI. Thereafter, the antibody responses to these 3 viral proteins of PRRS virus continued to be detected throughout the 105-day study period.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7578443     DOI: 10.1177/104063879500700302

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  42 in total

1.  The presence of alpha interferon at the time of infection alters the innate and adaptive immune responses to porcine reproductive and respiratory syndrome virus.

Authors:  Susan L Brockmeier; Crystal L Loving; Eric A Nelson; Laura C Miller; Tracy L Nicholson; Karen B Register; Marvin J Grubman; Douglas E Brough; Marcus E Kehrli
Journal:  Clin Vaccine Immunol       Date:  2012-02-01

2.  Performance of ELISA antigens prepared from 8 isolates of porcine reproductive and respiratory syndrome virus with homologous and heterologous antisera.

Authors:  H J Cho; S C Entz; R Magar; H S Joo
Journal:  Can J Vet Res       Date:  1997-10       Impact factor: 1.310

3.  Antigenic importance of the carboxy-terminal beta-strand of the porcine reproductive and respiratory syndrome virus nucleocapsid protein.

Authors:  S Wootton; G Koljesar; L Yang; K J Yoon; D Yoo
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

4.  Comparison of molecular and biological characteristics of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (ingelvac PRRS MLV), the parent strain of the vaccine (ATCC VR2332), ATCC VR2385, and two recent field isolates of PRRSV.

Authors:  T Opriessnig; P G Halbur; K-J Yoon; R M Pogranichniy; K M Harmon; R Evans; K F Key; F J Pallares; P Thomas; X J Meng
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Reproductive parameters following a PRRS outbreak where a whole-herd PRRS MLV vaccination strategy was instituted post-outbreak.

Authors:  Em-on Olanratmanee; Suparlark Nuntawan Na Ayudhya; Roongroje Thanawongnuwech; Annop Kunavongkrit; Padet Tummaruk
Journal:  Trop Anim Health Prod       Date:  2012-12-02       Impact factor: 1.559

6.  North American porcine reproductive and respiratory syndrome viruses inhibit type I interferon production by plasmacytoid dendritic cells.

Authors:  Gabriela Calzada-Nova; William M Schnitzlein; Robert J Husmann; Federico A Zuckermann
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

7.  Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5.

Authors:  Jung-Ah Lee; Byungjoon Kwon; Fernando A Osorio; Asit K Pattnaik; Nak-Hyung Lee; Sang-Won Lee; Seung-Yong Park; Chang-Seon Song; In-Soo Choi; Joong-Bok Lee
Journal:  Vaccine       Date:  2014-05-09       Impact factor: 3.641

8.  Genetic relationships of antibody response, viremia level, and weight gain in pigs experimentally infected with porcine reproductive and respiratory syndrome virus1.

Authors:  Andrew S Hess; Ben R Trible; Melanie K Hess; Raymond R Rowland; Joan K Lunney; Graham S Plastow; Jack C M Dekkers
Journal:  J Anim Sci       Date:  2018-09-07       Impact factor: 3.159

9.  Kinetics of humoral immune response to the major structural proteins of the porcine reproductive and respiratory syndrome virus.

Authors:  H D Loemba; S Mounir; H Mardassi; D Archambault; S Dea
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

10.  Use of an experimental model to test the efficacy of planned exposure to live porcine reproductive and respiratory syndrome virus.

Authors:  Tanja Opriessnig; Rodney B Baker; Patrick G Halbur
Journal:  Clin Vaccine Immunol       Date:  2007-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.